These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12471142)

  • 1. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
    Schottelius AJ; Giesen C; Asadullah K; Fierro IM; Colgan SP; Bauman J; Guilford W; Perez HD; Parkinson JF
    J Immunol; 2002 Dec; 169(12):7063-70. PubMed ID: 12471142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
    Qiu FH; Devchand PR; Wada K; Serhan CN
    FASEB J; 2001 Dec; 15(14):2736-8. PubMed ID: 11687510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
    Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
    Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
    Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
    J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
    Ariel A; Chiang N; Arita M; Petasis NA; Serhan CN
    J Immunol; 2003 Jun; 170(12):6266-72. PubMed ID: 12794159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
    Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
    J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo.
    Goh J; Baird AW; O'Keane C; Watson RW; Cottell D; Bernasconi G; Petasis NA; Godson C; Brady HR; MacMathuna P
    J Immunol; 2001 Sep; 167(5):2772-80. PubMed ID: 11509622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
    J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators.
    Wada K; Qiu FH; Stahl GL; Serhan CN
    J Hematother Stem Cell Res; 2001 Feb; 10(1):75-9. PubMed ID: 11276361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking.
    Bandeira-Melo C; Bozza PT; Diaz BL; Cordeiro RS; Jose PJ; Martins MA; Serhan CN
    J Immunol; 2000 Mar; 164(5):2267-71. PubMed ID: 10679058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.
    Bannenberg G; Moussignac RL; Gronert K; Devchand PR; Schmidt BA; Guilford WJ; Bauman JG; Subramanyam B; Perez HD; Parkinson JF; Serhan CN
    Br J Pharmacol; 2004 Sep; 143(1):43-52. PubMed ID: 15302682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators.
    Serhan CN; Jain A; Marleau S; Clish C; Kantarci A; Behbehani B; Colgan SP; Stahl GL; Merched A; Petasis NA; Chan L; Van Dyke TE
    J Immunol; 2003 Dec; 171(12):6856-65. PubMed ID: 14662892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
    József L; Zouki C; Petasis NA; Serhan CN; Filep JG
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13266-71. PubMed ID: 12235371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.
    Clish CB; O'Brien JA; Gronert K; Stahl GL; Petasis NA; Serhan CN
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8247-52. PubMed ID: 10393980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation.
    Clish CB; Levy BD; Chiang N; Tai HH; Serhan CN
    J Biol Chem; 2000 Aug; 275(33):25372-80. PubMed ID: 10837478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).
    Fierro IM; Kutok JL; Serhan CN
    J Pharmacol Exp Ther; 2002 Feb; 300(2):385-92. PubMed ID: 11805195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
    Pouliot M; Serhan CN
    J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN; Chiang N
    ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.